![](/img/cover-not-exists.png)
THU0623 Patient-Reported Outcomes from A Phase 3 Study of Baricitinib in Patients with Early Rheumatoid Arthritis Who Had Received Limited or No Treatment with Disease-Modifying anti-Rheumatic Drugs: Table 1.
Schiff, M., Takeuchi, T., Gaich, C., DeLozier, A.M., Schlichting, D., Kuo, W.-L., Durez, P., Carmack, T., Won, J.-E., Fleischmann, R.Volume:
75
Language:
english
Journal:
Annals of the Rheumatic Diseases
DOI:
10.1136/annrheumdis-2016-eular.1248
Date:
June, 2016
File:
PDF, 67 KB
english, 2016